Tom Ceska

1.4k total citations
16 papers, 669 citations indexed

About

Tom Ceska is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Tom Ceska has authored 16 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Immunology. Recurrent topics in Tom Ceska's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Receptor Mechanisms and Signaling (3 papers) and Neuropeptides and Animal Physiology (3 papers). Tom Ceska is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Receptor Mechanisms and Signaling (3 papers) and Neuropeptides and Animal Physiology (3 papers). Tom Ceska collaborates with scholars based in United Kingdom, United States and Belgium. Tom Ceska's co-authors include Florence Lebon, Alastair D. G. Lawson, David McMillan, Tong Sun Kobilka, Martyn Wood, Zara A. Sands, Bingfa Sun, Brian K. Kobilka, John Porter and Tim Bourne and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Tom Ceska

16 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Ceska United Kingdom 13 393 137 126 117 94 16 669
Osamu Kusano‐Arai Japan 13 464 1.2× 154 1.1× 155 1.2× 57 0.5× 58 0.6× 25 644
Jack M. Webster United States 20 770 2.0× 204 1.5× 376 3.0× 78 0.7× 73 0.8× 32 1.3k
Robbin Brodbeck United States 18 682 1.7× 332 2.4× 82 0.7× 281 2.4× 15 0.2× 37 1.2k
Matti Myllykoski Finland 17 674 1.7× 190 1.4× 26 0.2× 79 0.7× 39 0.4× 28 991
Rebecca M. Perrett United Kingdom 16 810 2.1× 91 0.7× 27 0.2× 97 0.8× 86 0.9× 26 1.1k
Changwook Lee South Korea 19 947 2.4× 66 0.5× 69 0.5× 63 0.5× 15 0.2× 43 1.3k
Christine Lavoie Canada 20 801 2.0× 156 1.1× 23 0.2× 66 0.6× 34 0.4× 43 1.2k
J Buciak United States 9 392 1.0× 149 1.1× 162 1.3× 71 0.6× 22 0.2× 9 906
Mehrdad Jannatipour United States 17 765 1.9× 149 1.1× 74 0.6× 135 1.2× 63 0.7× 20 1.2k
Anastasia Velentza United States 15 557 1.4× 130 0.9× 17 0.1× 102 0.9× 20 0.2× 19 914

Countries citing papers authored by Tom Ceska

Since Specialization
Citations

This map shows the geographic impact of Tom Ceska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Ceska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Ceska more than expected).

Fields of papers citing papers by Tom Ceska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Ceska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Ceska. The network helps show where Tom Ceska may publish in the future.

Co-authorship network of co-authors of Tom Ceska

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Ceska. A scholar is included among the top collaborators of Tom Ceska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Ceska. Tom Ceska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hall, Adrian, Jan Abendroth, Tom Ceska, et al.. (2022). Discovery and Characterization of a Novel Series of Chloropyrimidines as Covalent Inhibitors of the Kinase MSK1. ACS Medicinal Chemistry Letters. 13(7). 1099–1108. 7 indexed citations
2.
Sun, Bingfa, Dan Feng, Matthew Ling-Hon Chu, et al.. (2021). Crystal structure of dopamine D1 receptor in complex with G protein and a non-catechol agonist. Nature Communications. 12(1). 3305–3305. 37 indexed citations
3.
Higgins, A.J., Vincent L. G. Postis, Jonathan D. Lippiat, et al.. (2021). Cycloalkane-modified amphiphilic polymers provide direct extraction of membrane proteins for CryoEM analysis. Communications Biology. 4(1). 18 indexed citations
4.
Lightwood, Daniel, John Porter, David McMillan, et al.. (2021). A conformation-selective monoclonal antibody against a small molecule-stabilised signalling-deficient form of TNF. Nature Communications. 12(1). 583–583. 22 indexed citations
5.
McMillan, David, C. Martinez-Fleites, John Porter, et al.. (2021). Structural insights into the disruption of TNF-TNFR1 signalling by small molecules stabilising a distorted TNF. Nature Communications. 12(1). 582–582. 63 indexed citations
6.
Ceska, Tom, Andrew J. Beavil, Alistair J. Henry, et al.. (2020). Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc complex crystallization. Acta Crystallographica Section F Structural Biology Communications. 76(3). 116–129. 6 indexed citations
7.
Ceska, Tom, et al.. (2019). Cryo-EM in drug discovery. Biochemical Society Transactions. 47(1). 281–293. 32 indexed citations
8.
O’Connell, James P., John Porter, Stephen Rapecki, et al.. (2019). Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer. Nature Communications. 10(1). 5795–5795. 81 indexed citations
9.
Liu, Xiaofeng, Richard D. Taylor, Laura Griffin, et al.. (2017). Computational design of an epitope-specific Keap1 binding antibody using hotspot residues grafting and CDR loop swapping. Scientific Reports. 7(1). 41306–41306. 30 indexed citations
10.
Davies, Anna M., Anthony H. Keeble, Benjamin P. Cossins, et al.. (2017). Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab. Journal of Biological Chemistry. 292(24). 9975–9987. 62 indexed citations
11.
Sun, Bingfa, Matthew Chu, Martyn Wood, et al.. (2017). Crystal structure of the adenosine A2Areceptor bound to an antagonist reveals a potential allosteric pocket. Proceedings of the National Academy of Sciences. 114(8). 2066–2071. 101 indexed citations
12.
AlMalki, Faizah A., Min Feng, Svetlana E. Sedelnikova, et al.. (2016). Direct observation of DNA threading in flap endonuclease complexes. Nature Structural & Molecular Biology. 23(7). 640–646. 31 indexed citations
14.
Heifetz, Alexander, Gebhard F. X. Schertler, Roland Seifert, et al.. (2015). GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1–2 September 2014. Naunyn-Schmiedeberg s Archives of Pharmacology. 388(8). 883–903. 28 indexed citations
15.
Benoit, Roger, Daniel Frey, Manuel Hilbert, et al.. (2013). Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A. Nature. 505(7481). 108–111. 102 indexed citations
16.
Smith, Bengt, Tom Ceska, Anthony Turner, et al.. (2008). P150 DETAILING THE NOVEL STRUCTURE OF THE BIOPHARMACEUTICAL CERTOLIZUMAB PEGOL. 2(1). 50–50. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026